Comparison timestamp: 2025-05-06 17:43:59 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html
Live cdc.gov URL ↗: https://www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html
Live cdc.gov URL ↗: https://www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/nhsn/hai-report/data-tables-adult/table-13.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to site content Skip directly to searchEspañol | Other LanguagesHere's how you knowAn official website of the United States government Here's how you knowHealthcare-Associated Infections (HAIs)Healthcare-Associated Infections (HAIs)Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Healthcare-Associated Infections (HAIs)SearchSearch Menu Navigation Menu× Search NHSNSearch NHSN All CDCSubmitHealthcare-Associated Infections (HAIs)* Narrative & Commentary* Data Tables - Adult HAIs* Data Tables - Pediatric HAIs* Technical Resources* Healthcare-Associated Infections (HAIs) HomeHealthcare-Associated Infections (HAIs)Healthcare-Associated Infections (HAIs) HomeCDC's website is being modified to comply with President Trump's Executive Orders.HAI Pathogens and Antimicrobial Resistance Report, 2018-2021HAI Pathogens and Antimicrobial Resistance Report, 2018-2021Adult Data TablesPAGE 14 of 19‹View Table of ContentsTable 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats1, by Mucosal Barrier Injury (MBI) Status, Adults, 2018-2021Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status, Adults, 2018-2021MBI-LCBIs Non-MBI LCBIsPathogen, Antimicrobial Phenotype2 # Reported % Tested %R # Reported % Tested %RUrgent Threats Select Enterobacterales3 5,182 1,306Carbapenem-resistant (CRE) 74.6 3.6 73.4 2.7Serious Threats Select Enterobacterales4 4,605 1,094Extended-spectrum cephalosporin-NS 81.5 32.5 83.7 22.4Enterobacter spp. 546 195Cefepime-NS 77.1 13.5 74.4 3.4Enterococcus faecalis 609 361Vancomycin-resistant (VRE) 86.5 5.9 89.8 2.5Enterococcus faecium 1,535 439Vancomycin-resistant (VRE) 88.8 72.0 92.3 64.7Note: Refer to Technical Resources for more information about phenotype definitions, acronyms, and terms used in this table.Footnotes:1. As classified by CDC’s 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance [PDF – 10.7 MB]2. MBI-LCBIs cannot be reported with Acinetobacter spp., Pseudomonas aeruginosa, or Staphylococcus aureus pathogens. Therefore, antimicrobial resistance phenotypes for these pathogens are not shown.3. Consists of E. coli, Klebsiella oxytoca, Klebsiella pneumoniae, Klebsiella aerogenes, and Enterobacter spp.4. Consists of E. coli, Klebsiella oxytoca, and Klebsiella pneumoniae.HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type4. Table 3. The Top 15 HAI Pathogens Reported to NHSN5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type10. Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type14. ›Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI TypeLast Reviewed: July 28, 2023Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP)* Syndicatehome HAI Pathogens and Antimicrobial Resistance Report 2018-2021* Narrative & Commentary* Data Tables - Adult HAIs* Data Tables - Pediatric HAIs* Technical Resources* About CDC* Contact Us* 800-232-4636Facebook Twitter Instagram LinkedIn Youtube Pinterest SnapchatFacebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS* CONTACT CDCContact UsCall 800-232-4636Email Us* ABOUT CDC+ About CDC+ Jobs+ Funding* POLICIES+ Accessibility+ External Links+ Privacy+ Policies+ Web Policies+ No Fear Act+ FOIA+ OIG+ No Fear Act+ Nondiscrimination+ Vulnerability Disclosure Policy+ CDC Archive+ Public Health Publications+ HHS.gov+ USA.gov* CONNECT WITH US+ Youtube+ Snapchat* LANGUAGES+ Español+ 繁體中文+ Tiếng Việt+ 한국어+ Tagalog+ Русский+ العربية+ Kreyòl Ayisyen+ Français+ Polski+ Português+ Italiano+ Deutsch+ 日本語+ فارسی+ English* U.S. Department of Health & Human Services* Accessibility* External Links* Privacy* Policies* Web Policies* FOIA* OIG* No Fear Act* FOIA* Nondiscrimination* OIG* Vulnerability Disclosure Policy* CDC Archive* Public Health Publications* HHS.gov* USA.govContent Credential×This image was edited or created using GenAI (generative artificial intelligence).Our experts review all images in an effort to ensure accuracy and quality before use.Learn more about CDC's usage of GenAI.
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.